Terms: = Thyroid cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Prognosis
7 results:
1. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
2. Associations of Nutritional, Environmental, and Metabolic Biomarkers with Diabetes-Related Mortality in U.S. Adults: The Third National Health and Nutrition Examination Surveys between 1988-1994 and 2016.
Zhang X; Ardeshirrouhanifard S; Li J; Li M; Dai H; Song Y
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807807
[TBL] [Abstract] [Full Text] [Related]
3. BOP1 confers chemoresistance of triple-negative breast cancer by promoting cbp-mediated β-catenin acetylation.
Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
[TBL] [Abstract] [Full Text] [Related]
4. LINC01857 as an oncogene regulates CREB1 activation by interacting with crebbp in breast cancer.
Xiong Y; Gu Y; Wang F; Li L; Zhu M; Wang N; Mi H; Qiu X
J Cell Physiol; 2019 Aug; 234(8):14031-14039. PubMed ID: 30628071
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis.
Yang XG; Lun DX; Hu YC; Liu YH; Wang F; Feng JT; Hua KC; Yang L; Zhang H; Xu MY; Zhang HR
BMC Cancer; 2018 Dec; 18(1):1248. PubMed ID: 30545326
[TBL] [Abstract] [Full Text] [Related]
6. A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Pusceddu S; Barretta F; Trama A; Botta L; Milione M; Buzzoni R; De Braud F; Mazzaferro V; Pastorino U; Seregni E; Mariani L; Gatta G; Di Bartolomeo M; Femia D; Prinzi N; Coppa J; Panzuto F; Antonuzzo L; Bajetta E; Brizzi MP; Campana D; Catena L; Comber H; Dwane F; Fazio N; Faggiano A; Giuffrida D; Henau K; Ibrahim T; Marconcini R; Massironi S; Žakelj MP; Spada F; Tafuto S; Van Eycken E; Van der Zwan JM; Žagar T; Giacomelli L; Miceli R;
Endocr Relat Cancer; 2018 Jun; 25(6):607-618. PubMed ID: 29559553
[TBL] [Abstract] [Full Text] [Related]
7. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.
Cetta F; Olschwang S; Petracci M; Montalto G; Baldi C; Zuckermann M; Mariani Costantini R; Fusco A
World J Surg; 1998 Dec; 22(12):1231-6. PubMed ID: 9841749
[TBL] [Abstract] [Full Text] [Related]
